Business
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026
Fresenius Medical Care highlights new renal research and innovation at ERA Congress
About this update from Fresenius Se & Co. Kgaa
[{"type":"text","content":"Hemodiafiltration (HDF) research reinforces Fresenius Medical Care's continued leadership in advancing evidence-based dialysis care and treatment personalizationNew research focuses on applying real-world evidence, patient-centered outcomes and artificial intelligence across dialysis modalities and continuity of kidney careA preview of kinexus, a unified digital platform intended to support home dialysis programs by connecting therapy management and care workflowsBAD HOMBURG, Germany, May 27, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with kidney diseases, presents new research highlighting ongoing innovation at the European Renal Association (ERA) Congress 2026, June 3-6 in Glasgow, Scotland, and virtually. The Company highlights advancements including new hemodiafiltration research that reaffirm its leadership in evidence based and personalized dialysis care, real-world evidence to strengthen patient centered outcomes across dialysis modalities, and the application of artificial intelligence (AI) to improve patient outcomes.\"Fresenius Medical Care is focused on the research that can meaningfully advance the standard of care for people living with kidney disease,\" said Charles Hugh-Jones, Global Chief Medical Officer at Fresenius Medical Care. \"At ERA Congress 2026, we continue demonstrating our Company's leadership in evidence-based hemodiafiltration research and present abstracts covering the use of real-world evidence, patient-centered outcomes and artificial intelligence that are designed to help clinicians make better informed decisions and support patients across multiple care settings.\"FME's Global Medical Office and Renal Research Institute (RRI) teams present multiple abstracts across a range of critical topics in nephrology, demonstrating how data, artificial intelligence, and patient-centered outcomes are shaping the future of kidney care.Key presentations include:Impact of Matching and Weighting Strategy on Patient Retention and 3‑Year Mortality in Real‑World Hemodialysis and Hemodiafiltration: In a real-world analysis, hemodiafiltration was associated with lower three-year mortality risk than hemodialysis, with consistent results across different comparison methods.The Association Between Patient‑Reported Dialysis Recovery Time a...